has a place in the effort to avert acute attacks; however, its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 27 in The ...

We should like to emphasize the fact that this therapy is recommended only when the diagnosis of acute intractable bronchial asthma is certain since it might be hazardous if used in the treatment ...

Treatment at the point of an exacerbation for this type of asthma has barely changed for over 50 years, with steroid drugs being the mainstay of medication. Steroids such as prednisolone can ...

Pegtarazimod is under clinical development by ReAlta Life Sciences and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.

Asthma and COPD exacerbations cause nearly four million deaths worldwide each year, but treatment for the chronic conditions has not changed in five decades, she noted. Reuters ...